Objective The presence of microalbuminuria is a renal marker of vascular endothelial damage, and is an independent and strong predictor of increased risk for cardiovascular mortality and morbidity. Elevated circulating C-reactive protein (CRP) levels have recently been reported to be a novel cardiovascular risk factor, and it has been suggested that this acute-phase protein impairs vascular endothelial function. The aim of the present study was to determine whether serum CRP level is a dependent or an independent risk factor of microalbuminuria in the general population.
Introduction
Several epidemiological and clinical studies have demonstrated that the presence of microalbuminuria is an independent and strong predictor of increased risk for cardiovascular mortality and morbidity in certain high-risk groups such as patients with diabetes and hypertension (1) (2) (3) . In the general population, Hillege et al have recently reported that increased urinary albumin excretion as well as microalbuminuria were associated with increased cardiovascular and noncardiovascular mortality, independent of other classical cardiovascular risk factors (4) . These observations suggest that microalbuminuria is the renal expression of general vascular damage and a marker of atherosclerosis not only in specific subjects with an accumulated cardiovascular risk but also in a subjects with relatively lower risks.
Several nested case-control studies have shown that circulating levels of C-reactive protein (CRP) are correlated with an increased risk of myocardial infarction (5), stroke (6) , pe-ripheral arterial disease (7) , and sudden cardiac death (8) . A recent study has shown that in a general female population serum CRP levels are a strong predictor of cardiovascular events independent of traditional major risk factors (9) . In in vitro studies, exogenously applied CRP has been reported to impair vascular endothelial expression of nitric oxide synthase (10, 11) , and to upregulate endothelial expression of chemokines and adhesion molecules (12, 13) . As the presence of microalbuminuria is a marker of vascular endothelial damage (14) (15) (16) , it might be expected that the degree of urinary albumin excretion is enhanced by elevated circulating levels of CRP.
However, few previous studies have examined the relationship between microalbuminuria and serum CRP levels in the general population. In order to search for a new cardiovascular risk screening strategy, it will be necessary to examine the relationships among established risk factors and contemporary candidates. This cross-sectional study therefore examined the correlation between microalbuminuria and serum CRP levels after adjustment for established risk factors in apparently healthy Japanese men and women.
Methods

Study population
The Iwate-Kenpoku cohort (Iwate-KENCO) study is designed to prospectively investigate the risks of acute myocardial infarction, chronic congestive heart failure, stroke, and malignant tumor in a general adult population in northern Japan. This study was conducted as a part of a governmentregulated multiphasic health checkup for the general population over 40 years of age, based on the act of Health and Medical Service Act for the Elderly (1981). The study design incorporated a baseline survey which consisted of a selfadministered questionnaire on lifestyle, a food-frequency questionnaire, blood pressure measurement, ECG, anthropometrical measurement, and collections of blood and urine. A follow-up survey assessing mortality, migration, and the incidence of cardiovascular diseases, stroke and cancer is planned to be carried out after the baseline study. The survey population in this study included 4 rural communities in Ninohe district (Ichinohe town, Ninohe city, Kunohe village, and Karumai town) in the northern Iwate prefecture, Japan. This region has a resident population of 38,987 adults over the age of 40 years (male; 18,096: female; 20,891). Invitations to participate in the multiphasic health screening programme were issued by government offices in each community. In 2002, 3,878 males and 6,978 females (total, 10,856) aged 40 years and over took part in the programme. Of these participants, 9,051 (male; 3,227, female; 5,824) agreed to join the study (acceptance rate; 83.4%). This study protocol was approved by our university ethics committee and local institutional review committees. All participants gave written informed consent.
Subjects were excluded from the present analysis if their specimens were incomplete or they did not agree to the withdrawal of additional samples for urinary albumin or serum CRP measurement. Subjects without anthropometrical data were also excluded. In addition, subjects with the following characteristics were excluded; history of cardiovascular events such as stroke (n=238) or acute myocardial infarction (n=42), hematuria determined by a dipstick test (n=633), menstruating (n=56), micturition pain (n=18), and over 80 years of age (n=321). For the final statistical analysis, those with macroalbuminuria as defined by a urinary albumin-to-creatinine ratio (UACR) of 300 mg/g were excluded (17) . The final statistical analysis was therefore performed in 2,236 men and 4,217 women (Table 1 ).
Measurements
Subjects used a self-reported questionnaire to document medical history including status (yes or no) of prescribed drugs for hypertension, diabetes, hypercholesterolemia, micturition pain (yes or no), stroke, angina, and myocardial infarction. Family history, clinical symptoms, smoking habits (current or non-smoker), alcohol intake (yes or no), and nutrient intake were also assessed by a questionnaire developed by the study committee. Systolic and diastolic blood pressures were determined with an automated sphygmomanometer (BP103i II, Nippon Colin, Komaki, Japan), placed on the right arm of seated subjects who had rested in a sitting position for at least 5 minutes before the measurement. Measurement was performed twice, with the mean value used for statistical analysis. Hypertension was defined as systolic blood pressure 140 mm Hg and/or diastolic blood pressure 90 mm Hg, and/or the use of antihypertensive medication. Body height was measured with participants in stocking feet and weight was measured wearing light clothing. Body mass index was calculated as weight (kg) divided by the square of height (m 2 ). Obesity was specified as body mass index 27.8 kg/m 2 in men, and 27.3 kg/m 2 in women (18). Diabetes was ascertained either by self-reported physician diagnosis or by a measured non-fasting glucose concentration 200 mg/dl and/or HbA1c value 6.5%. Non-fasting blood samples were drawn from the antecubital vein of seated participants with minimal tourniquet use. Samples were collected into vacuum tubes containing ethylenediaminetetraacetic acid (glucose, HbA1c), or a serum separator gel (CRP, lipids). Tubes were stored immediately after sampling in an icebox and were transported to the central laboratory (Iwate Health Service Association) within 8 hours of collection. They were then centrifuged at 1,500 for 10 minutes. After separation, the serum samples were stored at 4°C, and measurements were then performed. Otherwise, samples were stored frozen at -20°C until the time of assay. High sensitivity serum CRP levels were measured by the latex-enhanced immunonephelometric method (N Latex CRP, Dade Behring). Both within-and betweenassay quality control procedures were used and the coefficient of variation (CV) of the method was less than 2%. The value in the calibrator was assigned from CRM 470 (IRMM, Geel, Belgium), an international plasma protein reference material. The minimal detectable concentration of this assay system was 0.10 mg/l. Enzymatic methods were used to measure serum total cholesterol levels, and serum creatinine. Blood glucose was determined using an enzymatic method (Kanto Kagaku, Tokyo, Japan). Glycosylated hemoglobin (HbA1c) was measured quantitatively with an HPLC method (Tosoh, Tokyo, Japan). Hematuria was semi-quantified by a dipstick test and was defined by more than +1.
A spot urine was collected, cooled and transported to the Iwate Health Service Association laboratory during each afternoon and analyzed on the same day. Urine albumin was assessed quantitatively by an immunonephelometric method (N-antiserum albumin, Dade Behring) and urine creatinine was measured quantitatively by an enzymatic colorimetric test. The UACR was used since the accuracy of the ratio in comparison to 24-hour urine sample has been demonstrated in previous papers (19, 20) . The sensitivity limit for albumin was 6 mg/l. Interassay and intraassay CV were both within 5%. Subjects showing levels below the sensitivity limit were regarded as 'no microalbuminuria' irrespective of their urine creatinine concentration.
Statistical analysis
We used Student's test to evaluate differences in means and chi-square tests to evaluate differences in proportions. Trends analysis was used to test for associations between increasing levels of UACR and known risks of microalbuminuria and serum CRP levels were divided into UACR quartiles. To define microalbuminuria in random urine specimens, we used the UACR cutoff point recommended by the American Diabetes Association (17) and the National Kidney Foundation (UACR >30 mg/g) (21) . For comparison of mean values among quartiles one-way analysis of variance was used. To test the independent relationships among serum CRP, microalbuminuria, and several continuous or categorical parameters (age, hypertension, obesity, hypercholesterolemia, smoking, diabetes), a multivariate logistic regression analysis was used to estimate odds ratio and 95% confidence intervals. Since serum CRP levels were not normally distributed, the value was logarithmically transformed for the above mentioned statistical analysis. All statistical analysis was performed using SPSS software (Chicago, Illinois, USA). A significant difference was defined as p<0.05.
Results
The characteristics of the population by sex are listed in Table 1 . Subject ages ranged from 40 to 79 years for both sexes. Although obesity was more common among women, current smoking and drinking were significantly higher in men. Serum total cholesterol levels, percentages of hypercholesterolemic subjects and anti-hyperlipidemic drug use were higher in women compared to men.
The distribution of serum CRP levels and UACR among study subjects was highly skewed toward the lower levels ( Figs. 1 and 2 ). The 25th, 50th, and 75th percentile values of CRP were 0.20, 0.50, and 1.0 mg/l in men, and 0.20, 0.40, and 0.80 mg/l in women. The 25th, 50th, and 75th percentile values of UACR were 7.1, 11.5, and 22.8 mg/g in men, and 8.7, 14.1, and 24.9 mg/g in women. Table 2 shows several cardiovascular risk factors among UACR quartile groups in men. Age, systolic blood pressure, diastolic blood pressure, and serum CRP were elevated with increasing levels of UACR. In women, age, systolic blood pressure, diastolic blood pressure, body mass index, incidence of obesity, and serum CRP levels were increased with UACR levels, whereas the percentage of current alcohol drinker was decreased (Table 3) .
In a logistic model for the prediction of microalbuminuria, age, obesity, hypertension, diabetes, and serum CRP levels were independently associated with the presence of microalbuminuria in both sexes (Table 4) . When subjects with diabetes were excluded from the analysis, serum CRP levels continued to be a significant predictor for microalbuminuria in both sexes. However, when subjects with obesity and/or diabetes were excluded, a significant relationship between microalbuminuria and serum CRP was observed only in men. As several kinds of antihypertensive medications have been reported to reduce urinary albumin excretion in patients with essential hypertension (22, 23) , analysis was performed after exclusion of subjects taking any antihypertensive medications. The relationship between serum CRP levels and microalbuminuria was persistent.
To eliminate the effect of estrogen replacement therapies on plasma CRP levels (24), subjects (n=40) who had been visiting a gynecologist (and were therefore possible users of estrogen) were excluded from the analysis. Despite this exclusion the observed relationship between serum CRP levels and microalbuminuria was still significant (odds ratio=1.251, 95% CI=1.053-1.487; p<0.02). In addition, to eliminate the effect of statins on serum CRP levels (25, 26) , the same multivariate regression analysis was performed after exclusion of subjects taking anti-hyperlipidemic drugs (men, n=82; women, n=343). Once again, the effect of CRP on microalbuminuria remained significant in both men (odds ratio=1.479, 95% CI=1.168-1.873; p<0.01) and women (odds ratio=1.270, 95% CI=1.060-1.522; p<0.01).
Discussion
After adjustment for several confounding factors related to albuminuria using a multivariate analysis, we found that serum CRP levels are significantly associated with microalbuminuria in the general population. This correlation was obvious even after exclusion of subjects with diabetes. This observation suggests that low-grade inflammation as assessed by high serum sensitive CRP levels may play a role in the induction of microalbuminuria, and that urinary albumin excretion rate reflects not only established cardiovascular risk factors but also systemic low-grade inflammation in an apparently healthy population. In fact, several studies have shown that microalbuminuria is evident in subjects with central obesity without an apparent relationship to hypertension and diabetes (27, 28) .
When subjects with obesity and/or diabetes were excluded from the present analysis, we found that the association between serum CRP levels and microalbuminuria persisted only in the male cohort. Although the reason for the gender difference in the correlation after exclusion of diabetes and obesity remains unknown, the impact of low-grade inflammation on vascular endothelial dysfunction, an important factor in the development of microalbuminuria (16) , may be obscure in women with low cardiovascular risk factors. In fact, several clinical and experimental studies have shown that endothelial nitric oxide production/release is higher in females (29, 30) . The differing nature of endothelial function between men and women may be a reason for the observed gender differences in non-obese and non-diabetic subjects.
The percentage of subjects receiving anti-hypercholesterolemic agents in this study cohort was approximately five percent. This class of the drug has been reported to decrease serum CRP levels in subjects with hypercholesterolemia (25, 26) . It follows that overall serum CRP levels in users of these drug might be decreased, modifying the relationship between serum CRP and microalbuminuria. However, when subjects receiving anti-hypercholesterolemic agents were excluded from the analysis, the original results persisted.
Several studies have demonstrated that estrogen replacement therapies increase serum CRP concentrations (24) . This effect may also alter the relationship between serum CRP and microalbuminuria in women. Although we did not check for the use of estrogen in our participants, the prevalence of hormone replacement therapy use in a community-based Japanese population has been reported to be very low compared to other countries (31) . Because estrogen replacement therapies are usually prescribed by gynecologists after hysterectomy in this country, we elected to exclude subjects attending gynecologists from the analysis. Despite this exclusion the relationship between CRP and microalbuminuria remained significant, suggesting that it is unlikely that hormone replacement therapies significantly modify the association.
It is possible that the observed correlation between microalbuminuria and serum CRP in the general population may be due to bias in the selection of subjects from the general population. However, the present study covered about 20% of the age-matched population in the area. Moreover, frequencies of hypertension and history of stroke, the distribution of plasma total cholesterol, random blood glucose level and body mass index of this cohort were comparable to those from a recent national healthy survey in a randomly selected Japanese adults population (32) .
The limitation of the present study is that serum CRP concentrations seen in percentile levels such as 25th, 50th and 75th in this study population are clearly lower than those seen in populations of differing ethnicity (33) . However, our observation is consistent with a recent Japanese nationwide epidemiological study (34) . The prevalence of microalbuminuria in the present study may be relatively higher than that seen in other races (35) , although few studies have examined the prevalence of microalbuminuria in general populations with a mean age over 60 years. It may be speculated that a higher prevalence of microalbuminuria with lower serum CRP levels is a specific characteristic of the Japanese population. It may therefore be uncertain to generalize from the present results to other populations.
In conclusion, the present study has shown that low-grade inflammation as represented by serum high sensitivity CRP levels may be significantly related to the presence of microalbuminuria in the general population. This suggests that the presence of microalbuminuria may be a useful marker representing low-grade systemic inflammation as well as established cardiovascular risk factors in apparently healthy individuals. 
